Lab will aid skin cancer treatment plans
Posted 7/31/2009
Posted in
A new research laboratory established at BIDMC will enable cancer specialists to characterize molecular abnormalities in individual melanomas and help physicians provide more personalized treatment and clinical research approaches.
The Michael Egan Memorial Research Laboratory for Melanoma Translational Research was established in part through a $100,000 gift from BJ's Wholesale Club.
The lab will chiefly serve to genetically classify tumors from patients with stage III or stage IV melanoma. Specifically, analyses will be performed on patient tumor tissue to evaluate for the presence of cancer-causing mutations of genes.
Egan was the chief executive officer of TransMolecular Inc., an oncology-focused biotechnology company in Cambridge and husband of BJ's Wholesale Club President & CEO Laura Sen, and had been a patient of Atkins.
For more, click here.
Tags: